SCHEMBL24064837

SCHEMBL24064837

CCCCCCC(C)(C)C(C)(C)CCCCCCCNCCCCC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.62
ALDH1A1 P00352 1/20 0.62
S1PR2 O95136 5/20 0.45
S1PR4 O95977 5/20 0.45
S1PR1 P21453 5/20 0.45
S1PR3 Q99500 5/20 0.45
S1PR5 Q9H228 1/20 0.45
EPHX1 P07099 4/20 0.44
ADH1B P00325 1/20 0.44
ADH1C P00326 1/20 0.44
ADH1A P07327 1/20 0.44
ADH4 P08319 1/20 0.44
ADH7 P40394 1/20 0.44
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28590555 0.87 TSHR (0.52) TSHRALDH1A1S1PR2S1PR4S1PR1
Hydrochloric Acid SCHEMBL30471377 0.86 ALDH1A1 (0.50) TSHRALDH1A1S1PR2S1PR4S1PR1
Bromide SCHEMBL31572063 0.86 ALDH1A1 (0.50) TSHRALDH1A1S1PR2S1PR4S1PR1
SCHEMBL27947144 0.84 TSHR (0.53) TSHRTHRB
SCHEMBL486995 0.84 TSHR (0.87) TSHRALDH1A1S1PR2S1PR4S1PR1
Bromide SCHEMBL27973525 0.84 TSHR (0.59) TSHRALDH1A1S1PR2S1PR4S1PR1
Hydrochloric Acid SCHEMBL6032005 0.84 TSHR (0.59) TSHRALDH1A1S1PR2S1PR4S1PR1
Chloromethane SCHEMBL27919857 0.82 TSHR (0.81) TSHRALDH1A1S1PR2S1PR4S1PR1
Octane SCHEMBL9281542 0.82 TSHR (0.50) TSHRTHRB
Chloromethane SCHEMBL27565490 0.82 TSHR (0.81) TSHRALDH1A1S1PR2S1PR4S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11479599-B2 Antibodies against SARS-CoV-2 and methods of using the same Vir Biotechnology, Inc. (US) 2022-10-25 US disclosed
US-20210371504-A1 ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME Vir Biotechnology, Inc. 2021-12-02 US disclosed